Research ArticleBasic Science Investigations
Diels–Alder Reaction for Tumor Pretargeting: In Vivo Chemistry Can Boost Tumor Radiation Dose Compared with Directly Labeled Antibody
Raffaella Rossin, Tilman Läppchen, Sandra M. van den Bosch, Richard Laforest and Marc S. Robillard
Journal of Nuclear Medicine November 2013, 54 (11) 1989-1995; DOI: https://doi.org/10.2967/jnumed.113.123745
Raffaella Rossin
1Department of Minimally Invasive Healthcare, Philips Research, Eindhoven, The Netherlands; and
Tilman Läppchen
1Department of Minimally Invasive Healthcare, Philips Research, Eindhoven, The Netherlands; and
Sandra M. van den Bosch
1Department of Minimally Invasive Healthcare, Philips Research, Eindhoven, The Netherlands; and
Richard Laforest
2Division of Radiological Sciences, Washington University School of Medicine, St. Louis, Missouri
Marc S. Robillard
1Department of Minimally Invasive Healthcare, Philips Research, Eindhoven, The Netherlands; and

Data supplements
Supplemental Data
Files in this Data Supplement:
In this issue
Journal of Nuclear Medicine
Vol. 54, Issue 11
November 1, 2013
Diels–Alder Reaction for Tumor Pretargeting: In Vivo Chemistry Can Boost Tumor Radiation Dose Compared with Directly Labeled Antibody
Raffaella Rossin, Tilman Läppchen, Sandra M. van den Bosch, Richard Laforest, Marc S. Robillard
Journal of Nuclear Medicine Nov 2013, 54 (11) 1989-1995; DOI: 10.2967/jnumed.113.123745
Diels–Alder Reaction for Tumor Pretargeting: In Vivo Chemistry Can Boost Tumor Radiation Dose Compared with Directly Labeled Antibody
Raffaella Rossin, Tilman Läppchen, Sandra M. van den Bosch, Richard Laforest, Marc S. Robillard
Journal of Nuclear Medicine Nov 2013, 54 (11) 1989-1995; DOI: 10.2967/jnumed.113.123745
Jump to section
Related Articles
Cited By...
- PET imaging of an antisense oligonucleotide in the living non-human primate brain using click chemistry
- Advantage of the F(ab)2 fragment over IgG for RIT and PRIT
- Effect of Modulating FcRn Binding on Direct and Pretargeted Tumor Uptake of Full-length Antibodies
- Pretargeted Imaging and Therapy
- Establishment of the In Vivo Efficacy of Pretargeted Radioimmunotherapy Utilizing Inverse Electron Demand Diels-Alder Click Chemistry
- Comparative Analysis of Bispecific Antibody and Streptavidin-Targeted Radioimmunotherapy for B-cell Cancers
- Pretargeted Immuno-PET of Pancreatic Cancer: Overcoming Circulating Antigen and Internalized Antibody to Reduce Radiation Doses
- Diabody Pretargeting with Click Chemistry In Vivo